Ignite Creation Date:
2025-12-26 @ 10:36 AM
Ignite Modification Date:
2025-12-29 @ 2:09 PM
Study NCT ID:
NCT06923228
Status:
NOT_YET_RECRUITING
Last Update Posted:
2025-04-11
First Post:
2025-04-04
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study to Assess Efficacy and Safety of CGB-500, 1% Tofacitinib Versus an Active Comparator for Atopic Dermatitis
Sponsor:
CAGE Bio Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-04-21
Start Date Type:
ESTIMATED
Primary Completion Date:
2025-07-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-09-30
Completion Date Type:
ESTIMATED
First Submit Date:
2025-04-04
First Submit QC Date:
None
Study First Post Date:
2025-04-11
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-04-10
Last Update Post Date:
2025-04-11
Last Update Post Date Type:
ACTUAL